Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
SPRAVATO Drug Insight and Market Forecast – 2032
... SPRAVATO for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along with a ... Read More
-
Global Clinical Trials Support Services Market Forecast 2022-2030
... by the rising prevalence of chronic disease & virus outbreaks and various benefits of clinical trial support services. MARKET INSIGHTS Clinical trials are controlled studies on humans to ensure the efficacy of drugs, food, and ... Read More
-
Asia-pacific Clinical Trials Support Services Market Forecast 2022-2030
... high-quality data at a low price and the presence of a huge population drive market growth. MARKET INSIGHTS The Asia-Pacific clinical trials support services market growth evaluation entails the analysis of Japan, China, Singapore, South ... Read More
-
Europe Clinical Trials Support Services Market Forecast 2022-2030
... and high-quality patient data accelerate market growth in the region. MARKET INSIGHTS The Europe clinical trials support services market growth assessment entails the evaluation of Germany, France, Denmark, Hungary, United Kingdom, Spain, Sweden, Italy, and ... Read More
-
North America Clinical Trials Support Services Market Forecast 2022-2030
... and cost-saving technologies and the presence of numerous market players boost the market growth in the region. MARKET INSIGHTS The North America clinical trials support services market growth analysis entails the evaluation of Canada and ... Read More
-
Global eClinical solutions Market Size, Share & Industry Trends Analysis Report By Delivery Mode, By Product, By Clinical Trials Phase (Phase III, Phase II, Phase IV and Phase I), By End User, By Regional Outlook and Forecast, 2022 - 2028
... and Forecast, 2022 - 2028 The Global eClinical solutions Market size is expected to reach $20.1 billion by 2028, rising at a market growth of 13.6% CAGR during the forecast period. With professional data services ... Read More
-
Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 80 million diagnosed prevalent cases of urticaria across 16 pharmaceutical markets. Most of the leading marketed drugs for urticaria are second-generation H1-antihistamines, which are used as the first-line symptomatic treatment for the disease. Out ... Read More
-
North America eClinical solutions Market Size, Share & Industry Trends Analysis Report By Delivery Mode, By Product, By Clinical Trials Phase (Phase III, Phase II, Phase IV and Phase I), By End User, By Country and Growth Forecast, 2022 - 2028
... and Growth Forecast, 2022 - 2028 The North America eClinical solutions Market would witness market growth of 12.9% CAGR during the forecast period (2022-2028). Clinical trial data is known to be gathered and managed by ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022
... or in the pipeline. The data is assessed, and the different products are compared against each other both clinically and commercially. This report is an update of the previous COVID-19 Clinical and Commercial analyzer, which ... Read More
-
Methicillin-Resistant Staphylococcus Aureus (MRSA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... will be more than 859,000 incident cases of MRSA across seven major pharmaceutical markets. There are eight leading marketed drugs for the treatment of MRSA; Pfizer is a key player in the disease space. R&D ... Read More
-
Diabetic Macular Edema Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... the macula, located in the center of the retina, which consequently becomes swollen due to accumulation of excess fluid and results in impaired vision or even blindness. The loss of central vision can negatively impact ... Read More
-
Europe eClinical solutions Market Size, Share & Industry Trends Analysis Report By Delivery Mode, By Product, By Clinical Trials Phase (Phase III, Phase II, Phase IV and Phase I), By End User, By Country and Growth Forecast, 2022 - 2028
... Growth Forecast, 2022 - 2028 The Europe eClinical solutions Market would witness market growth of 13.1% CAGR during the forecast period (2022-2028). The main factor influencing the use of eClinical solutions, particularly in industrialized nations ... Read More
-
Fungal Infections Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than three million incident cases of fungal Infections across 16 pharmaceutical markets. There are several marketed innovator drugs for the treatment of fungal infections, mostly cytochrome P450 and beta glucan synthase enzyme inhibitors. ... Read More
-
Rabies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Rabies (Infectious Disease) pipeline landscape. Rabies is a deadly virus spread to people from the saliva of infected animals. The rabies virus is usually transmitted through a bite. Symptoms include loss of ... Read More
-
Essential Thrombocythemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Essential Thrombocythemia (Oncology) pipeline landscape. Essential thrombocythemia is a chronic myeloproliferative neoplasm in which cells in the bone marrow that produce the blood cells develop and function abnormally. In essential ... Read More
-
Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Osteoporosis (Metabolic Disorders) pipeline landscape. Osteoporosis, or thinning bones, makes bones weak and more likely to break. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or ... Read More
-
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Cathepsin L, a lysosomal endopeptidase is a member of the papain-like family of cysteine proteinases. Cathepsin L plays a major role in antigen processing, ... Read More
-
Corneal Neovascularization Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Corneal Neovascularization (Ophthalmology) pipeline landscape. Corneal neovascularization is a corneal condition where oxygen deprivation and stress cause abnormal blood vessels to grow in the normally clear, translucent cornea. Predisposing factors ... Read More
-
Ventricular Tachycardia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Ventricular Tachycardia (Cardiovascular) pipeline landscape. Ventricular tachycardia is a very fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia include dizziness, fainting, fatigue, chest pain and shortness ... Read More
-
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Arterial Disease (PAD) Peripheral Vascular Disease (PVD) - Drugs In Development, 2022, provides an overview of the Peripheral Arterial Disease (PAD) Peripheral Vascular Disease (PVD) (Cardiovascular) pipeline landscape. Peripheral vascular disease (PVD) refers to diseases ... Read More
-
Saudi Arabia AI-based Clinical Trials Solution Provider Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028
... and competitive study of the Saudi Arabia market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Saudi Arabia market. Also, factors that are driving and ... Read More
-
Vietnam AI-based Clinical Trials Solution Provider Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028
... study of the Vietnam market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Vietnam market. Also, factors that are driving and restraining the AI-based clinical ... Read More
-
Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... 'Collagenase 3 - Drugs In Development, 2022'; Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are developed by companies and ... Read More
-
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... the recently published report 'Histone Deacetylase 6 - Drugs In Development, 2022'; Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) pipeline Target constitutes close to 53 molecules. Out of ... Read More
-
Idiopathic Pulmonary Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Idiopathic Pulmonary Fibrosis (Respiratory) pipeline landscape. Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease characterized by inflammation and scarring of lung tissue and loss of lung ... Read More
Research Assistance
